Cybin Inc. Reports Strong Growth and Progress in Mental Healthcare Innovations
Update: 2025-11-13
Description
Cybin Inc., a leading neuropsychiatry company, recently announced its successful second-quarter results and highlighted key advancements in its clinical trials and global regulatory approvals. With a focus on revolutionizing mental healthcare, Cybin is actively developing new treatment options for conditions like major depressive disorder and generalized anxiety disorder. George Tziras, the chief business officer, will be presenting at the Jefferies Global Healthcare Conference in London to discuss the company's innovative approach to mental health treatments.
Comments
In Channel
Download from Google Play
Download from App Store
United States00:00
00:00
x
